NOVELLO, Silvia
NOVELLO, Silvia
ONCOLOGIA
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA
2012-01-01 Lo Iacono M; Roetto A; Monica V; Boero M; Vavala T; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV
Angiogenesis in stage in Non-Small-Cell Lung cancer (NSCLC) expression of Human protesa - activated receptors (PARS)
2004-01-01 GHIO P; SELVAGGI G; NOVELLO S; CAPPIA S; PAPOTTI M; GIORIO S; CAGGESE D; BORASIO P; LAUSI P; SCAGLIOTTI GV
Bronchopleural fistula after pneumonectomy for lung cancer. Consideration of 450 consecutive cases
2005-01-01 C. Mossetti; P. Lausi; F. Ardissone; E. Manzone; G. Selvaggi; S. Novello; P. Borasio
Clinical and biological significance of CD157 in malignant pleural mesothelioma
2011-01-01 S. Morone; E. Ortolan; A. Giacomino; R. Parrotta; N. Lo Buono; I. Rapa; L. Righi; M. Volante; E. Ruffini; S. Demichelis; G. Rovere; S. Novello; F. Malavasi; A. Funaro.
Current state-of-the-art therapy for advanced squamous cell lung cancer
2013-01-01 Scagliotti, Giorgio V.; Novello, Silvia; Rapetti, Simonetta; Papotti, Mauro
Detection of EGFR mutations in archival lung cancer samples by pyrosequencing
2011-01-01 Cappia S; Cuccurullo A; Giachino D; Righi L; Bacillo E; De Risi C; Rovere G; Novello S; Papotti M
Differential expression of DNA repair machinery genes in normal bronchial tissue and non-small cell lung cancer (NSCLC)
2008-01-01 G. Selvaggi; S. Saviozzi; P. Ceppi; M. Volante; M. Lo Iacono; S. Novello; M. Longo; R. Calogero; M. Papotti; G. V. Scagliotti
Low-dose spiral CT for early diagnosis of lung cancer in a light risk population: 2-year results
2004-01-01 SCAGLIOTTI GV; BORASIO P; DOGLIOTTI L; FAVA C; CORTESE G; CRIDA B; SELVAGGI G; SAINI; CARDINALE L; PLACIDO R; GRIVETTO S; NOVELLO S.
Mammalian target of rapamycin (MTOR) signaling activation patterns in neuroendocrine tumors of the lung
2008-01-01 Righi L; Volante M; Tavaglione V; Rosas R; Filosso PL; Novello S; Ardissone F; Papotti M.
MDM2 309 and TP53 Arg72Pro single nucleotide polymorphisms (SNPs) and clinical outcome in advanced lung cancer patients
2007-01-01 S. Novello; G. Mandrile; D. F. Giachino; P. Ghio; G. Selvaggi; D. Gregori; M. De Marchi; G. V. Scagliotti
Non small cell lung cancer (NSCLC): accuracy of FGD PET/CT un the preoperative mediastinal nodal staging
2007-01-01 E. Pelosi; A. Billè; A. Skanjeti; V. Arena; A. Douroukas; S. Novello; G.V. Scagliotti; F. Ardissone; P. Borasio.
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center
2021-01-01 Bungaro, M; Bertaglia, V; Audisio, M; Parlagreco, E; Pisano, C; Cetoretta, V; Persano, I; Jacobs, F; Baratelli, C; Consito, L; Reale, ML; Tabbo, F; Bironzo, P; Scagliotti, G; Novello, S
Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapy
2005-01-01 Giachino, Daniela Francesca; Ghio, P.; Regazzoni, S.; Mandrile, Giorgia; Novello, Silvia; Selvaggi, G.; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio
Pharmacogenetics studies in patients with advanced lungcancer: prognostic value of the thymidylate synthase 2R/3Rpolymorphism and predictivity of NER factor XPD K751Qand XRCC1 R399Q polymorphisms following platinum-basedchemotherapy
2005-01-01 Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; SelvaggiG; De Marchi; Scagliotti GV
Prospective study assessing MDM2 309 and p53 Arg72Pro single nucleotide polymorphism (SNPs) and clinical outcome in advanced lung cancer
2007-01-01 Mandrile, Giorgia; Giachino, Daniela Francesca; Novello, Silvia; Paolo, Ghio; Giovanni, Selvaggi; Gregori, Dario; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio
Role of Second Line Chemotherapy and New Target Treatment in Recurrent Mesothelioma
2019-01-01 Novello, S; Bironzo, P
The NFKBIA’s amplification in cancer, emerging molecular targets for lung cancer therapy
2019-01-01 Giovanna Carrà, Rocco Piazza, Giuseppe Ermondi, Giulia Caron, Chiara Riganti, Beatrice Maffeo, Antonio Cartellà, Marcello Francesco Lingua, Mara Brancaccio, Riccardo Taulli, Silvia Novello; Alessandro Morotti
Thymidylate synthase expression in large cell carcinoma ofthe lung
2009-01-01 Scagliotti Giorgio V.; Monica Valentina; Ceppi Paolo; Righi Luisella; Cambieri Alberto; Lo Iacono Marco; Volante Marco; Novello Silvia; Papotti Mauro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA | 2012 | Lo Iacono M; Roetto A; Monica V; Boero M; Vavala T; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV | |
| Angiogenesis in stage in Non-Small-Cell Lung cancer (NSCLC) expression of Human protesa - activated receptors (PARS) | 2004 | GHIO P; SELVAGGI G; NOVELLO S; CAPPIA S; PAPOTTI M; GIORIO S; CAGGESE D; BORASIO P; LAUSI P; SCAGLIOTTI GV | |
| Bronchopleural fistula after pneumonectomy for lung cancer. Consideration of 450 consecutive cases | 2005 | C. Mossetti; P. Lausi; F. Ardissone; E. Manzone; G. Selvaggi; S. Novello; P. Borasio | |
| Clinical and biological significance of CD157 in malignant pleural mesothelioma | 2011 | S. Morone; E. Ortolan; A. Giacomino; R. Parrotta; N. Lo Buono; I. Rapa; L. Righi; M. Volante; E. Ruffini; S. Demichelis; G. Rovere; S. Novello; F. Malavasi; A. Funaro. | |
| Current state-of-the-art therapy for advanced squamous cell lung cancer | 2013 | Scagliotti, Giorgio V.; Novello, Silvia; Rapetti, Simonetta; Papotti, Mauro | |
| Detection of EGFR mutations in archival lung cancer samples by pyrosequencing | 2011 | Cappia S; Cuccurullo A; Giachino D; Righi L; Bacillo E; De Risi C; Rovere G; Novello S; Papotti M | |
| Differential expression of DNA repair machinery genes in normal bronchial tissue and non-small cell lung cancer (NSCLC) | 2008 | G. Selvaggi; S. Saviozzi; P. Ceppi; M. Volante; M. Lo Iacono; S. Novello; M. Longo; R. Calogero; M. Papotti; G. V. Scagliotti | |
| Low-dose spiral CT for early diagnosis of lung cancer in a light risk population: 2-year results | 2004 | SCAGLIOTTI GV; BORASIO P; DOGLIOTTI L; FAVA C; CORTESE G; CRIDA B; SELVAGGI G; SAINI; CARDINALE L; PLACIDO R; GRIVETTO S; NOVELLO S. | |
| Mammalian target of rapamycin (MTOR) signaling activation patterns in neuroendocrine tumors of the lung | 2008 | Righi L; Volante M; Tavaglione V; Rosas R; Filosso PL; Novello S; Ardissone F; Papotti M. | |
| MDM2 309 and TP53 Arg72Pro single nucleotide polymorphisms (SNPs) and clinical outcome in advanced lung cancer patients | 2007 | S. Novello; G. Mandrile; D. F. Giachino; P. Ghio; G. Selvaggi; D. Gregori; M. De Marchi; G. V. Scagliotti | |
| Non small cell lung cancer (NSCLC): accuracy of FGD PET/CT un the preoperative mediastinal nodal staging | 2007 | E. Pelosi; A. Billè; A. Skanjeti; V. Arena; A. Douroukas; S. Novello; G.V. Scagliotti; F. Ardissone; P. Borasio. | |
| Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center | 2021 | Bungaro, M; Bertaglia, V; Audisio, M; Parlagreco, E; Pisano, C; Cetoretta, V; Persano, I; Jacobs, F; Baratelli, C; Consito, L; Reale, ML; Tabbo, F; Bironzo, P; Scagliotti, G; Novello, S | |
| Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapy | 2005 | Giachino, Daniela Francesca; Ghio, P.; Regazzoni, S.; Mandrile, Giorgia; Novello, Silvia; Selvaggi, G.; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio | |
| Pharmacogenetics studies in patients with advanced lungcancer: prognostic value of the thymidylate synthase 2R/3Rpolymorphism and predictivity of NER factor XPD K751Qand XRCC1 R399Q polymorphisms following platinum-basedchemotherapy | 2005 | Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; SelvaggiG; De Marchi; Scagliotti GV | |
| Prospective study assessing MDM2 309 and p53 Arg72Pro single nucleotide polymorphism (SNPs) and clinical outcome in advanced lung cancer | 2007 | Mandrile, Giorgia; Giachino, Daniela Francesca; Novello, Silvia; Paolo, Ghio; Giovanni, Selvaggi; Gregori, Dario; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio | |
| Role of Second Line Chemotherapy and New Target Treatment in Recurrent Mesothelioma | 2019 | Novello, S; Bironzo, P | |
| The NFKBIA’s amplification in cancer, emerging molecular targets for lung cancer therapy | 2019 | Giovanna Carrà, Rocco Piazza, Giuseppe Ermondi, Giulia Caron, Chiara Riganti, Beatrice Maffeo, Antonio Cartellà, Marcello Francesco Lingua, Mara Brancaccio, Riccardo Taulli, Silvia Novello; Alessandro Morotti | |
| Thymidylate synthase expression in large cell carcinoma ofthe lung | 2009 | Scagliotti Giorgio V.; Monica Valentina; Ceppi Paolo; Righi Luisella; Cambieri Alberto; Lo Iacono Marco; Volante Marco; Novello Silvia; Papotti Mauro |